Respiratory Medicine

Article	Citations
Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19)	275
Follow up of patients with severe coronavirus disease 2019 (COVID-19): Pulmonary and extrapulmonary disease sequelae	220
Diagnostic performance between CT and initial real-time RT-PCR for clinically suspected 2019 coronavirus disease (COVID-19) patients outside Wuhan, China	190
Pulmonary pathology of ARDS in COVID-19: A pathological review for clinicians	179
Severe respiratory SARS-CoV2 infection: Does ACE2 receptor matter?	138
Goals of COPD treatment: Focus on symptoms and exacerbations	131
Pulmonary function and health-related quality of life after COVID-19 pneumonia	117
A study on infectivity of asymptomatic SARS-CoV-2 carriers	109
Underlying respiratory diseases, specifically COPD, and smoking are associated with severe COVID-19 outcomes: A systematic review and meta-analysis	94
Levels of resilience, anxiety and depression in nurses working in respiratory clinical areas during the COVID pandemic	89
Smoking and COVID-19: What we know so far	79
Integrative respiratory follow-up of severe COVID-19 reveals common functional and lung imaging sequelae	78
Practical strategies for a safe and effective delivery of aerosolized medications to patients with COVID-19	74
D-dimer in patients infected with COVID-19 and suspected pulmonary embolism	69
The role of oral microbiome in respiratory health and diseases	59
Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: An observational longitudin	59
Significant reduction in hospital admissions for acute exacerbation of chronic obstructive pulmonary disease in Hong Kong during coronavirus disease 2019 pandemic	56
Clinical outcomes and quality of life of COVID-19 survivors: A follow-up of 3 months post hospital discharge	54
Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry	52
COVID-19: Why does disease severity vary among individuals?	51
Predictors of mortality in fibrosing pulmonary sarcoidosis	48
Sex differences between women and men with COPD: A new analysis of the 3CIA study	47
Fixed-dose combination of indacaterol/glycopyrronium/mometasone furoate once-daily versus salmeterol/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: A randomis	46
Correlation analysis of the severity and clinical prognosis of 32 cases of patients with COVID-19	46
Pneumothorax in critically ill patients with COVID-19 infection: Incidence, clinical characteristics and outcomes in a case control multicenter study	44

Respiratory rehabilitation for Covid-19 related persistent dyspnoea: A one-year experience	44
Idiopathic pulmonary hemosiderosis: A state of the art review	44
Colchicine and SARS-CoV-2: Management of the hyperinflammatory state	42
Six-minute walk distance in healthy young adults	42
Candida spp. co-infection in COVID-19 patients with severe pneumonia: Prevalence study and associated risk factors	41
Health-related quality of life profiles, trajectories, persistent symptoms and pulmonary function one year after ICU discharge in invasively ventilated COVID-19 patients, a prospective follow-up study	41
“Current place of impulse oscillometry in the assessment of pulmonary diseases.”	40
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity	40
Evaluation and management of pulmonary arterial hypertension	38
Residual ground glass opacities three months after Covid-19 pneumonia correlate to alteration of respiratory function: The post Covid M3 study	37
Managing malnutrition in COPD: A review	37
Anti-Ro52 antibody is an independent risk factor for interstitial lung disease in dermatomyositis	37
Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey	36
Complications after discharge with COVID-19 infection and risk factors associated with development of post-COVID pulmonary fibrosis	36
Poor outcome of SARS-CoV-2 infection in patients with severe asthma on biologic therapy	36
Tobacco use as a well-recognized cause of severe COVID-19 manifestations	36
Risk factors and associated outcomes of hospital readmission in COPD: A systematic review	35
Follow-up of functional exercise capacity in patients with COVID-19: It is improved by telerehabilitation	34
Investigating the aggressiveness of the COVID-19 Omicron variant and suggestions for possible treatment options	34
Clinical status and lung function 10 weeks after severe SARS-CoV-2 infection	34
Guidance on nebulization during the current COVID-19 pandemic	33
Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot study	32
Lung ultrasonography for long-term follow-up of COVID-19 survivors compared to chest CT scan	32
COVID-19 patients in a tertiary US hospital: Assessment of clinical course and predictors of the disease severity	32
Smoking and risk of COVID-19 hospitalization	31
Anti-Ro52 antibodies are a risk factor for interstitial lung disease in primary Sjögren syndrome	31
Efficacy of therapeutic plasma exchange in the treatment of penn class 3 and 4 cytokine release syndrome complicating COVID-19	31
Galectin-3 as prognostic biomarker in patients with COVID-19 acute respiratory failure	30
Long-term exposure to fine particulate matter and hospitalization in COVID-19 patients	30
Aquaporins in lung health and disease: Emerging roles, regulation, and clinical implications	29
Impaired diffusing capacity for carbon monoxide is common in critically ill Covid-19 patients at four months post-discharge	29
Multinational cohort study of mortality in patients with asthma and severe asthma	29
Use of corticosteroids in asthma and COPD patients with or without COVID-19	29
Pulmonary artery thrombi are co-located with opacifications in SARS-CoV2 induced ARDS	29
The effectiveness of pulmonary rehabilitation for Post-COVID symptoms: A rapid review of the literature	28
Controversy surrounding the Sputnik V vaccine	28
Moving towards a Treatable Traits model of care for the management of obstructive airways diseases	28
Non-CF bronchiectasis: Orphan disease no longer	28
Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposis	27
The association of anxiety and depression with mortality in a COPD cohort. The HUNT study, Norway	26
Efficacy and safety of rituximab in patients with chronic hypersensitivity pneumonitis (cHP): A retrospective, multicentric, observational study	26
The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients	26
Severity does not impact on exercise capacity in COVID-19 survivors	25
Volatile organic compounds associated with diagnosis and disease characteristics in asthma – A systematic review	25
Effectiveness and safety of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease with the Phe508del/minimal function genotype	25
ROX index as predictor of high flow nasal cannula therapy success in acute respiratory failure due to SARS-CoV-2	25
Sarcoidosis: A nationwide registry-based study of incidence, prevalence and diagnostic work-up	25
The impact of demographic disparities in the presentation of sarcoidosis: A multicenter prospective study	24
Role of inhaled corticosteroids in reducing exacerbations in bronchiectasis patients with blood eosinophilia pooled post-hoc analysis of 2 randomized clinical trials	24
Interim treatment outcomes in multidrug-resistant tuberculosis using bedaquiline and/or delamanid in South Korea	24

Disproportionate decline in admissions for exacerbated COPD during the COVID-19 pandemic	22
Ivacaftor improves lung disease in patients with advanced CF carrying CFTR mutations that confer residual function	22
Non-surgical treatment options for pulmonary aspergilloma	22
Aspiration pneumonia: A renewed perspective and practical approach	22
Identification of breath-prints for the COPD detection associated with smoking and household air pollution by electronic nose	21
The lived experience with pulmonary embolism: A qualitative study using focus groups	21
SARS-CoV-2 vaccines: A critical perspective through efficacy data and barriers to herd immunity	21
Chest X-ray features of SARS-CoV-2 in the emergency department: a multicenter experience from northern Italian hospitals	21
A prospective evaluation of lung function at three and six months in patients with previous SARS-COV-2 pneumonia	21
COVID-19 infection in severe Alpha 1-antitrypsin deficiency: Looking for a rationale	21
A systematic literature review of burden of illness in adults with uncontrolled moderate/severe asthma	21
Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry	21
Disease course and prognosis of pleuroparenchymal fibroelastosis compared with idiopathic pulmonary fibrosis	21
Asthma patients' and physicians’ perspectives on the burden and management of asthma	20
Epidemiology of nontuberculous mycobacterial pulmonary disease in Europe and Japan by Delphi estimation	20
Coronavirus Disease 2019-related dyspnea cases difficult to interpret using chest computed tomography	20
High-density lipoprotein cholesterol as a factor affecting virus clearance in covid-19 patients	20
Pharmacological management of COVID-19 patients with ARDS (CARDS): A narrative review	20
Ultra-low dose rituximab as add-on therapy in anti-MDA5-positive patients with polymyositis /dermatomyositis associated ILD	19
Effects of surgical and cloth facemasks during a submaximal exercise test in healthy adults	19
Characteristics and outcomes in hospitalized COVID-19 patients during the first 28 days of the spring and autumn pandemic waves in Milan: An observational prospective study	19
Idiopathic pulmonary fibrosis and gastroesophageal reflux disease: A population-based, case-control study	19
Platelets in chronic obstructive pulmonary disease: An update on pathophysiology and implications for antiplatelet therapy	19
Evolution of lung function and chest CT 6 months after COVID-19 pneumonia: Real-life data from a Belgian University Hospital	19
Decreased quality of life and spirometric alterations even after mild-moderate COVID-19	19
Predictors for progressive fibrosis in patients with connective tissue disease associated interstitial lung diseases	19
Prevalence of viral respiratory infections amongst asthmatics: Results of a meta-regression analysis	19
Survival in COPD patients treated with bronchoscopic lung volume reduction	18
Usefulness of the HACOR score in predicting success of CPAP in COVID-19-related hypoxemia	18
Prevalence and features of IOS-defined small airway disease across asthma severities	18
Electrical impedance tomography: A compass for the safe route to optimal PEEP	18
COPD phenotypes and machine learning cluster analysis: A systematic review and future research agenda	18
Current perspectives on the immunopathogenesis of sarcoidosis	18
Predictors of failure of high flow nasal cannula failure in acute hypoxemic respiratory failure due to COVID-19	17
Behavioural modification interventions alongside pulmonary rehabilitation improve COPD patients’ experiences of physical activity	17
12-months follow-up of pulmonary tele-rehabilitation versus standard pulmonary rehabilitation: A multicentre randomised clinical trial in patients with severe COPD	17
Large underreporting of COPD as cause of death-results from a population-based cohort study	17
Intestinal permeability marker zonulin as a predictor of sarcopenia in chronic obstructive pulmonary disease	17
Compliance in subcutaneous and sublingual allergen immunotherapy: A nationwide study	17
Exposures and associations with clinical phenotypes in hypersensitivity pneumonitis: A scoping review	17
Update on the diagnosis and management of malignant pleural effusions	17
Endothelial function provides early prognostic information in patients with COVID-19: A cohort study	17
The emerging role of oxidative stress in complications of COVID-19 and potential therapeutic approach to diminish oxidative stress	16
Alpha-1 antitrypsin deficiency severity and the risk of COVID-19: A Portuguese cohort	16
Emergency department admission and hospitalization for COPD exacerbation and particulate matter short-term exposure in Brescia, a highly polluted town in northern Italy	16
Association between chest CT features and clinical course of Coronavirus Disease 2019	16
Rates of depression and anxiety in Italian patients with cystic fibrosis and parent caregivers: Implementation of the Mental Health Guidelines	16
The effect of doxofylline in asthma and COPD	16
Diagnosis of tuberculous pleural effusions: A review	16
Diagnosis and quantification of bronchiectasis using computed tomography or magnetic resonance imaging: A systematic review	16
Risk factors for the development of post-infectious bronchiolitis obliterans after Mycoplasma pneumoniae pneumonia in the era of increasing macrolide resistance	16
The use of cough peak flow in the assessment of respiratory function in clinical practice- A narrative literature review	16
Comparability of asthma control test scores between self and physician-administered test	16
Diagnostic utility of endobronchial ultrasound (EBUS) features in differentiating malignant and benign lymph nodes - A systematic review and meta-analysis	16
Factors associated with anxiety and depression among patients with Covid-19	16
Clinical and biological factors associated with irreversible airway obstruction in adult asthma	15
Complications and hospital admission in the following 90 days after lung cryobiopsy performed in interstitial lung disease	15
Falls prevalence and risk factors in people with chronic obstructive pulmonary disease: A systematic review	15
Respiratory care for the critical patients with 2019 novel coronavirus	15
The association between white blood cell count and outcomes in patients with idiopathic pulmonary fibrosis	15
The impact of dysfunctional breathing on the level of asthma control in difficult asthma	15
Chronic rhinosinusitis in COPD: A prevalent but unrecognized comorbidity impacting health related quality of life	15
Preexisting cardiorespiratory comorbidity does not preclude the success of multidisciplinary rehabilitation in post-COVID-19 patients	15
Cognitive function following pulmonary rehabilitation and post-discharge recovery from exacerbation in people with COPD	15
Who are the 10%? - Non eligibility of cystic fibrosis (CF) patients for highly effective modulator therapies	15
Patient experiences of as-needed budesonide-formoterol by Turbuhaler® for treatment of mild asthma; a qualitative study	15
The six-minute walk test in sarcoidosis associated pulmonary hypertension: Results from an international registry	15
Frequent productive cough: Symptom burden and future exacerbation risk among patients with asthma and/or COPD in the NOVELTY study	14
Real-life evaluation of clinical outcomes in patients undergoing treatment for non-tuberculous mycobacteria lung disease: A ten-year cohort study	14
Asthma prevalence in patients with SARS-CoV-2 infection detected by RT-PCR not requiring hospitalization	14
Outcomes of SARS-CoV-2 infection in patients with cystic fibrosis: A multicenter retrospective research network study	14
Pectoralis muscle area and its association with indices of disease severity in interstitial lung disease	14
COPD is a risk factor for COVID-19, but does not confer increased severity of the disease	14
Extracellular DNA in sputum is associated with pulmonary function and hospitalization in patients with cystic fibrosis	14
Safe extubation during the COVID-19 pandemic	14
Chronic cough in Vocal Cord Dysfunction: Description of a clinical entity	14
The effects of oral corticosteroids on lung function, type-2 biomarkers and patient-reported outcomes in stable asthma: A systematic review and meta-analysis	14
Paediatric long term continuous positive airway pressure and noninvasive ventilation in France: A cross-sectional study	14
Depressive and anxiety symptoms in patients with COPD: A network analysis	14
Electronic medication monitors help determine adherence subgroups in asthma	14

COPD maintenance medication is linked to left atrial size: Results from the COSYCONET cohort	14
The cost-effectiveness of as-needed budesonide/formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in the UK	14
Patients with respiratory symptoms are at greater risk of COVID-19 transmission	14
Low income and outcome in idiopathic pulmonary fibrosis: An association to uncover	13
Outcomes of SARS-CoV-2 infection in patients with pulmonary sarcoidosis: A multicenter retrospective research network study	13
Differences in disease presentation between men and women with sarcoidosis: A cohort study	13
The potential utility of anterior upper lobe honeycomb-like lesion in interstitial lung disease associated with connective tissue disease	13
Increased serum soluble programmed death ligand 1(sPD-L1) is associated with the presence of interstitial lung disease in rheumatoid arthritis: A monocentric cross-sectional study	13
Asthma in COVID-19 patients: An extra chain fitting around the neck?	13
The influence of smoking on asthma in the real-life	13
German Respiratory Society guidelines for diagnosis and treatment of adults suffering from acute, subacute and chronic cough	13
Beneficial effects of inhaled surfactant in patients with COVID-19-associated acute respiratory distress syndrome	13
Preliminary observations on IGRA testing for TB infection in patients with severe COVID-19 eligible for immunosuppressive therapy	13
Mortality and readmission in the year following hospitalization for pneumonia among US adults	13
Randomised, placebo-controlled trial of dexamethasone for quality of life in pulmonary sarcoidosis	13
Effectiveness of a pharmacist-led intervention on inhalation technique for asthma and COPD patients: The INSPIRA pilot cluster-randomized controlled trial	13
Association of inhaled and systemic corticosteroid use with Coronavirus Disease 2019 (COVID-19) test positivity in patients with chronic pulmonary diseases	13
Adherence and persistence to once-daily single-inhaler versus multiple-inhaler triple therapy among patients with chronic obstructive pulmonary disease in the USA: A real-world study	13
Benefits of budesonide/glycopyrrolate/formoterol fumarate (BGF) on symptoms and quality of life in patients with COPD in the ETHOS trial	12
Corticosteroids and bone health in people with asthma: A systematic review and meta-analysis	12
Adult but not childhood onset asthma is associated with the metabolic syndrome, independent from body mass index	12
Lung imaging in bronchopulmonary dysplasia: a systematic review	12
Pleuroparenchymal fibroelastosis: Clinical, radiological and histopathological features	12
Prognostic significance of peripheral blood monocyte and neutrophil counts in rheumatoid arthritis-associated interstitial lung disease	12
Reduced pulmonary function, low-grade inflammation and increased risk of total and cardiovascular mortality in a general adult population: Prospective results from the Moli-sani study	12
Suggestions for lung function testing in the context of COVID-19	12
Clusters of comorbidities in idiopathic pulmonary fibrosis	12
Statins: cause of fibrosis or the opposite? Effect of cardiovascular drugs in idiopathic pulmonary fibrosis	12
Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registry	12
Association of sex with clinical outcomes in COVID-19 patients: A retrospective analysis of 1190 cases	12
Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease	12
The S100 calcium-binding protein A4 level is elevated in the lungs of patients with idiopathic pulmonary fibrosis	12
Predictive value of chest CT scoring in COVID-19 patients in Wuhan, China: A retrospective cohort study	12
Outcomes and prognostic factors of decompensated pulmonary hypertension in the intensive care unit	11
Non-invasive ventilation improves exercise tolerance and peripheral vascular function after high-intensity exercise in COPD-HF patients	11
In-line treatments and clinical initiatives to fight against COVID-19 outbreak	11
BPI-ANCA is expressed in the airways of cystic fibrosis patients and correlates to platelet numbers and Pseudomonas aeruginosa colonization	11
Increased asthma control after a 3-week inpatient pulmonary rehabilitation program	11
Covid-19 and in situ pulmonary artery thrombosis	11
Cardiopulmonary exercise testing in patients with asthma: What is its clinical value?	11
HLA-DRB1 alleles associate with hypercalcemia in sarcoidosis	11
Pulmonary nodular and cystic light chain deposition disease: A retrospective review of 10 cases	11
Association of obesity-related inflammatory pathways with lung function and exercise capacity	11
Non-response did not affect prevalence estimates of asthma and respiratory symptoms - results from a postal questionnaire survey of the general population	11
Risk of incident dementia and cognitive impairment in patients with chronic obstructive pulmonary disease (COPD): A large UK population-based study	11
Effect of azithromycin on bronchial wall thickness in severe persistent asthma: A double-blind placebo-controlled randomized clinical trial	11
Developing a short-term prediction model for asthma exacerbations from Swedish primary care patients’ data using machine learning - Based on the ARCTIC study	11
Exclusive ambulatory management of spontaneous pneumothorax with pigtail catheters, a prospective multicentric study	11
Oral corticosteroid sparing effects of anti-IL5/ anti-IL5 receptor treatment after 2 years of treatment	11
Use of Pneumococcal and influenza vaccine in patients with COPD, asthma bronchiale and interstitial lung diseases in south east Germany	11
Bronchodilator reversibility testing in post-COVID-19 patients undergoing pulmonary rehabilitation	11
High fitness levels offset the increased risk of chronic obstructive pulmonary disease due to low socioeconomic status: A cohort study	10
Utilization and determinants of use of non-pharmacological interventions in COPD: Results of the COSYCONET cohort	10
Multidimensional indices in the assessment of chronic obstructive pulmonary disease	10
Assessing the need for transfer to the intensive care unit for Coronavirus-19 disease: Epidemiology and risk factors	10
Pneumothorax and barotrauma in invasively ventilated patients with COVID-19	10
Patient characteristics associated with adherence to pulmonary nodule guidelines	10
Effect of patient immunodeficiencies on the diagnostic performance of serological assays to detect Aspergillus-specific antibodies in chronic pulmonary aspergillosis	10
Long COVID outcomes in an asthmatic cohort and its implications for asthma control	10
The role of lung macrophages in chronic obstructive pulmonary disease	10
Effect of an educational intervention delivered by pharmacists on adherence to treatment, disease control and lung function in patients with asthma	10
Breaking hearts and taking names: A case of sarcoidosis related effusive-constrictive pericarditis	10
Bronchiectasis and inhaled tobramycin: A literature review	10
Can FeNO be a biomarker in the post-COVID-19 patients monitoring?	10
COPD exacerbation phenotypes in a real-world five year hospitalisation cohort	10
Interventional and pharmacological management of chronic thromboembolic pulmonary hypertension	10
Effectiveness of pulmonary rehabilitation at high-altitude compared to sea-level in adults with severe refractory asthma	10
The 5T approach in asthma: Triple Therapy Targeting Treatable Traits	10
Pulmonary hypertension in end-stage renal disease	10
High expression of mTOR signaling in granulomatous lesions is not predictive for the clinical course of sarcoidosis	10
Distribution of chronic cough phenotypes in the general population: A cross-sectional analysis of the LEAD cohort in Austria	10
Clinical characteristics of and risk factors for small airway dysfunction detected by impulse oscillometry	10
Clinical characteristics of patients with anti-EJ antisynthetase syndrome associated interstitial lung disease and literature review	10
Frequency and characterization of CTEPH and CTEPD according to the mPAP threshold > 20 mm Hg: Retrospective analysis from data of a prospective PE aftercare program	9
SMART for the treatment of asthma: A network meta-analysis of real-world evidence	9
Urinary volatile organic compound metabolites and reduced lung function in U.S. adults	9
Clinical outcomes in Mycobacterium xenopi versus Mycobacterium avium complex pulmonary disease: A retrospective matched cohort study	9
Clinical and radiological characteristics of ultrasonic humidifier lung and summer-type hypersensitivity pneumonitis	9
A patient decision aid for mild asthma: Navigating a new asthma treatment paradigm	9
Oral corticosteroid prescription for asthma by general practitioners: A three-year analysis in Germany	9
Natural history of incidental sporadic and tuberous sclerosis complex associated lymphangioleiomyomatosis	9
Baseline lung allograft dysfunction in primary graft dysfunction survivors after lung transplantation	9
Immediate physiological effects of acute electronic cigarette use in humans: A systematic review and meta-analysis	9
Updated prevalence, predictors and treatment outcomes for bronchiolitis obliterans syndrome after allogeneic stem cell transplantation	9
Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma	9
Integrating digital inhalers into clinical care of patients with asthma and chronic obstructive pulmonary disease	9
Pneumocystis pneumonia after lung transplantation: A retrospective multicenter study	9
Assessment of dyspnea in sarcoidosis using the Baseline Dyspnea Index (BDI) and the Transition Dyspnea Index (TDI)	9
Corticosteroid refractory sarcoidosis	9
Exposure-efficacy analyses of nintedanib in patients with chronic fibrosing interstitial lung disease	9
Association of low FVC spirometric pattern with WTC occupational exposures	9
SARS-CoV-2 infection in alpha1-antitrypsin deficiency	9
The longitudinal use of EmPHasis-10 and CAMPHOR questionnaire health-related quality of life scores in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension	9
Acute exacerbations of COPD are associated with a prothrombotic state through platelet-monocyte complexes, endothelial activation and increased thrombin generation	9
Determining factors associated with inhaled therapy adherence on asthma and COPD: A systematic review and meta-analysis of the global literature	9